HAWTHORNE, N.Y.--(BUSINESS WIRE)--Acorda Therapeutics, Inc. (Nasdaq: ACOR) announced today that Douglas Kargman, M.D., M.S., has joined the Company as Vice President of Drug Safety, reporting to Thomas Wessel, M.D., Ph.D., Chief Medical Officer. Dr. Kargman will have responsibility for overseeing Acorda’s drug safety and risk management programs.
